No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
291 |
4. Check minimum number of eventsNone |
291 |
5. Include endpointsNone |
291 |
6. Filter based on genotype QC (FinnGen only) |
291 |
Control definitions (FinnGen only)
- Control exclude
- K11_MIH
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Hypoplasia of dental enamel, including avohilmo
based on the number of shared cases.
Similar with more cases:
- Hypoplasia of dental enamel , including avohilmo
- Molar incisor enamel hypoplasia
- Disorders of tooth development and eruption
- Diseases of oral cavity, salivary glands and jaws
- Gastrointestinal diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2239 | 1077 | 1161 |
| Only index persons | 1559 | 759 | 800 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | 0.03 |
| Only index persons | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 8.72 | 8.93 | 8.50 |
| Only index persons | 10.24 | 10.43 | 10.06 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 291 | 143 | 148 |
| Unadjusted period prevalence (%) | 0.06 | 0.05 | 0.07 |
| Median age at first event (years) | 8.74 | 9.48 | 8.03 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 263
- Matched controls
- 2628
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
+∞
323.0
263
*
127
Kela drug reimbursment
Transplant complication
113.5
107.4
112
17
H02AB09
ATC
hydrocortisone; systemic
35.2
103.7
140
82
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
38.6
96.4
125
60
Z2221
NOMESCO Finland
Medical doctor
21.3
94.7
226
585
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
39.3
88.9
114
50
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
112.9
85.8
90
12
H02AB04
ATC
methylprednisolone; systemic
42.5
84.6
106
41
Z94.0
ICD-10 Finland
Kidney transplant status
126.7
83.0
86
10
WX404
NOMESCO Finland
Intravenous generell anesthesy
15.8
82.6
216
591
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
31.1
82.4
113
62
ZXE10
NOMESCO Finland
More than one and less than three hours
15.6
80.8
218
623
ZXD05
NOMESCO Finland
Urgent procedure
14.2
80.8
184
371
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
17.1
77.9
140
164
L04AX01
ATC
azathioprine; systemic
31.4
74.4
101
51
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
13.5
72.8
152
241
A11CC03
ATC
alfacalcidol; systemic
59.9
71.8
83
20
K03.66
ICD-10 Finland
Tooth plaque
11.9
71.4
173
364
WX408
NOMESCO Finland
General anesthesy, balanced
11.9
67.8
213
694
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
91.1
67.5
73
11
ZX120
NOMESCO Finland
Intravenous
15.4
65.6
120
136
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
205.8
63.1
63
*
ZXE20
NOMESCO Finland
More than three and less than five hours
12.1
62.4
133
205
Z2446
NOMESCO Finland
Social worker
9.8
62.3
177
456
XF602
NOMESCO Finland
Bloodpressure monitoring
60.1
61.5
71
16
Z3226
NOMESCO Finland
Physiotherapist
9.7
61.2
197
617
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
104.9
60.1
64
8
L04AD01
ATC
ciclosporin; systemic
42.3
59.6
74
24
ZXD10
NOMESCO Finland
Scheduled procedure
10.4
59.0
218
833
L04AA06
ATC
mycophenolic acid; systemic
51.4
58.0
69
18
EBA15
NOMESCO Finland
Extraction of large number of teeth
23.6
57.7
85
52
R4110
NOMESCO Finland
Physiotherapy
8.8
57.1
184
551
137
Kela drug reimbursment
Uraemia requiring dialysis
180.8
56.4
57
*
ZXE00
NOMESCO Finland
One hour or less
10.4
56.1
223
918
GD1AA
NOMESCO Finland
Thorax X-ray examination
8.5
55.4
181
544
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
8.6
55.2
162
412
C08CA01
ATC
amlodipine; oral
28.6
54.6
75
36
205
Kela drug reimbursment
Chronic hypertension
34.2
54.4
71
28
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
16.3
53.7
92
84
B03XA01
ATC
erythropoietin; parenteral
168.9
53.1
54
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
20.0
51.4
80
56
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
9.2
51.1
128
245
Z3231
NOMESCO Finland
Registered nurse
9.4
50.6
224
996
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
96.4
50.1
54
7
K02.0
ICD-10 Finland
Caries limited to enamel
7.5
49.6
188
658
A12AA04
ATC
calcium carbonate; oral
84.3
49.3
54
8
SAA04
NOMESCO Finland
Special inverstigation of mouth
8.9
48.8
124
239
Z01.0
ICD-10 Finland
Examination of eyes and vision
7.4
47.2
147
382
602
Kela drug reimbursment
Children's severe malnutrition
13.4
47.1
88
95
K06.18
ICD-10 Finland
Another gingival hyperplasia
65.9
46.6
53
10
B05DA
ATC
Isotonic solutions
277.2
46.6
46
*
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
34.9
46.4
60
22
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
270.0
45.5
45
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
14.0
45.3
82
82
ZXA00
NOMESCO Finland
Right side
8.4
45.1
117
228
K00.41
ICD-10 Finland
Prenatal enamel hypoplasia
+∞
44.0
41
*
C08CA02
ATC
felodipine; oral
255.6
43.3
43
*
SAA03
NOMESCO Finland
Extended examination of mouth
13.3
43.1
247
1413
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
6.8
42.7
142
389
N04.80
ICD-10 Finland
Congenital nephrotic syndrome of the Finnish type
+∞
41.8
39
*
Z2445
NOMESCO Finland
Psychologist
6.9
41.4
129
320
Z49.2
ICD-10 Finland
Other dialysis
465.0
41.3
40
*
TPH07
NOMESCO Finland
Cathetrisation of artery
8.4
41.0
103
186
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
24.4
40.6
58
30
SCE00
NOMESCO Finland
Fissure closure of tooth
6.2
40.5
150
463
TPH04
NOMESCO Finland
Cathetrisation of vein
7.0
40.4
122
288
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
102.4
40.2
43
5
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
10.3
40.1
86
118
L04AA01
ATC
[U] ciclosporin; systemic
124.3
40.0
42
*
WX882
NOMESCO Finland
High dependency care
7.1
39.8
117
265
A41.9
ICD-10 Finland
Sepsis, unspecified
19.0
39.1
61
41
KAC00
NOMESCO Finland
Nephrectomy
73.0
38.5
43
7
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
82.7
38.2
42
6
Z94.4
ICD-10 Finland
Liver transplant status
117.4
37.9
40
*
C03CA01
ATC
furosemide; systemic
15.0
37.7
65
56
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
6.2
37.2
127
344
XF400
NOMESCO Finland
ECG with 12 standard connections
5.7
37.2
146
469
5AB14
NOMESCO Finland
NA
94.0
37.0
40
5
K03.00
ICD-10 Finland
Approximal wear
16.9
36.8
60
45
Z3229
NOMESCO Finland
Other healthcare associate professional
6.5
36.6
115
279
Z99.2
ICD-10 Finland
Dependence on renal dialysis
110.5
35.8
38
*
K06.19
ICD-10 Finland
Gingival hyperplasia UNS
75.8
35.1
39
6
XW000
NOMESCO Finland
Bone marrow biopsy
18.5
35.0
55
37
V03AG01
ATC
sodium cellulose phosphate; systemic
34.9
34.2
44
15
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
8.3
34.2
84
141
TK800
NOMESCO Finland
Hemodialysis
73.6
34.0
38
6
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
10.8
33.8
69
84
RD210
NOMESCO Finland
NA
7.3
33.8
92
180
FM2CE
NOMESCO Finland
NA
6.6
33.4
100
223
N18.8
ICD-10 Finland
Other chronic renal failure
33.9
33.3
43
15
WW500
NOMESCO Finland
Blood transfusion
13.8
33.1
59
54
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
14.0
32.9
58
52
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
6.5
32.8
99
222
ZXA05
NOMESCO Finland
Left side
7.1
32.6
91
183
ZXA10
NOMESCO Finland
Bilateral
5.6
32.4
117
327
R50.9
ICD-10 Finland
Fever, unspecified
5.1
31.9
138
471
B05DB
ATC
Hypertonic solutions
181.3
31.4
32
*
Z49.1
ICD-10 Finland
Extracorporeal dialysis
181.3
31.4
32
*
TK820
NOMESCO Finland
Peritoneal dialysis
94.0
30.5
33
*
C07AB02
ATC
metoprolol; systemic
14.8
30.4
52
43
ZX199
NOMESCO Finland
Other rote
21.8
30.0
44
24
F59
ICD-10 Finland
Unspecified behavioural syndromes associated with physiological disturbances and physical factors
23.1
29.9
43
22
BE00A
NOMESCO Finland
NA
116.6
29.3
31
*
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
21.5
28.5
42
23
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
11.5
28.5
55
59
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
5.6
28.1
96
244
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
4.6
28.0
131
467
C03DA01
ATC
spironolactone; oral
13.2
27.8
50
46
K03.64
ICD-10 Finland
Dental calculus supragingival
4.3
27.6
156
662
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.8
27.3
114
360
ZXE30
NOMESCO Finland
More than five and less than seven hours
7.4
27.1
70
123
TPX10
NOMESCO Finland
Implantation of vascular injection port
20.6
26.2
39
22
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
6.0
25.7
80
179
4AA09
NOMESCO Finland
NA
77.8
25.3
28
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
25.0
25.1
35
16
XX4AW
NOMESCO Finland
NA
9.3
24.6
53
69
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
6.6
24.3
68
132
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
24.2
24.2
34
16
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
13.3
23.7
42
37
ZX121
NOMESCO Finland
Central venous catheter
19.3
22.5
34
20
C09AA02
ATC
enalapril; systemic
11.7
22.3
42
42
IGY02
NOMESCO Finland
Psychiatric monitoring contact
5.7
22.1
70
157
RS220
NOMESCO Finland
NA
9.6
21.5
45
55
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
3.6
21.3
154
747
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
65.7
21.3
24
*
J05AB01
ATC
aciclovir; systemic
5.9
21.2
64
135
Z94.1
ICD-10 Finland
Heart transplant status
40.9
21.2
26
7
V03AE01
ATC
polystyrene sulfonate; oral
227.2
20.9
21
*
TAB00
NOMESCO Finland
Lumbar puncture
8.8
20.8
46
62
BC00A
NOMESCO Finland
NA
35.8
20.6
26
8
WX402
NOMESCO Finland
General anaesthesia
3.8
20.3
114
445
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
9.1
20.3
44
57
EB1WA
NOMESCO Finland
NA
62.7
20.2
23
*
C09CA01
ATC
losartan; oral
14.3
20.0
34
27
ZXD20
NOMESCO Finland
Day surgery
5.3
19.9
67
160
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.1
19.9
93
310
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
5.2
19.8
68
166
A05AA02
ATC
ursodeoxycholic acid; oral
17.6
19.3
30
19
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.2
19.3
85
267
201
Kela drug reimbursment
Chronic cardiac insufficiency
12.8
19.1
34
30
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
5.2
19.1
64
152
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.9
19.1
69
178
Z01.2
ICD-10 Finland
Dental examination
3.8
19.0
211
1365
A02BC01
ATC
omeprazole; systemic
4.9
18.9
69
179
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
4.0
18.8
88
291
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
4.6
18.7
73
203
K03.28
ICD-10 Finland
Other erosion of teeth
32.8
18.7
24
8
B34.9
ICD-10 Finland
Viral infection, unspecified
5.3
18.6
61
141
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
6.2
18.2
52
101
WX110
NOMESCO Finland
Local anesthesy
3.9
18.1
220
1495
XA800
NOMESCO Finland
Neuropsychological investigation
4.2
18.1
78
238
B03XA02
ATC
darbepoetin alfa; parenteral
102.0
17.8
19
*
6BA02
NOMESCO Finland
NA
20.4
17.7
26
14
RS221
NOMESCO Finland
NA
7.7
17.7
42
63
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
45.4
17.6
21
5
UDC00
NOMESCO Finland
Ear microscopy
5.1
17.5
59
140
H66.0
ICD-10 Finland
Acute suppurative otitis media
3.1
17.3
150
783
B01AA03
ATC
warfarin; systemic
10.9
17.2
33
34
F43.8
ICD-10 Finland
Other reactions to severe stress
23.8
17.2
24
11
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
12.0
17.0
31
29
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
67.9
17.0
19
*
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
37.8
16.9
21
6
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
3.8
16.9
223
1560
ZXE40
NOMESCO Finland
More than seven and less than nine hours
8.2
16.8
38
53
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
12.4
16.7
30
27
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
5.0
16.5
57
138
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
3.8
16.3
80
271
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
9.4
16.3
34
41
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
13.5
16.3
28
23
J01MA02
ATC
ciprofloxacin; systemic
5.8
16.1
48
98
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
17.1
16.1
25
16
WW200
NOMESCO Finland
Immunization
11.9
15.9
29
27
SDA02
NOMESCO Finland
Parodonthologic therapy
3.1
15.9
125
599
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
5.4
15.9
50
109
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
13.5
15.8
27
22
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.9
15.6
164
946
ZY010
NOMESCO Finland
Hospital outpatient
3.7
15.6
77
262
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
11.1
15.4
29
29
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
8.3
15.3
34
46
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.8
15.1
73
243
3A013
NOMESCO Finland
NA
60.3
15.0
17
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
8.2
14.8
33
45
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
13.7
14.7
25
20
XX4BW
NOMESCO Finland
NA
13.7
14.7
25
20
GD1LA
NOMESCO Finland
GD
+∞
14.7
14
*
TK823
NOMESCO Finland
Peritoneal permeability analysis
158.4
14.6
15
*
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
158.4
14.6
15
*
H02AB02
ATC
dexamethasone; systemic
11.4
14.6
27
26
XF600
NOMESCO Finland
Bloodpressure measurement
3.4
14.6
82
307
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
7.6
14.5
34
50
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
5.1
14.3
47
107
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.7
14.3
69
228
N18.0
ICD-10 Finland
End-stage renal disease
45.1
14.3
17
*
RK220
NOMESCO Finland
NA
13.8
14.2
24
19
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
11.4
14.1
26
25
K03.29
ICD-10 Finland
Erosion of teeth occupational
21.5
14.0
20
10
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
56.5
14.0
16
*
JAH00
NOMESCO Finland
Laparotomy
13.1
13.9
24
20
130
Kela drug reimbursment
Malignant tumour
13.9
13.7
23
18
C10AA03
ATC
pravastatin; oral
36.2
13.7
17
5
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
13.7
13
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
9.4
13.6
28
33
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
27.4
13.6
18
7
J05AB11
ATC
valaciclovir; oral
7.8
13.5
31
44
RL140
NOMESCO Finland
NA
7.1
13.4
33
52
R4190
NOMESCO Finland
Nutritional therapy
3.2
13.4
83
331
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
9.6
13.4
27
31
B07.9
ICD-10 Finland
Verruca simplex
5.7
13.3
39
78
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
12.5
13.1
23
20
ZX131
NOMESCO Finland
Intrathecal
24.0
13.1
18
8
J02AC01
ATC
fluconazole; systemic
4.2
12.7
51
142
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
4.5
12.6
47
122
WX002
NOMESCO Finland
Sedation and analgesia
3.9
12.6
55
166
XF622
NOMESCO Finland
Measurement of minute volume of heart
12.5
12.6
22
19
ZX114
NOMESCO Finland
Intramuscular
9.4
12.3
25
29
L03AA02
ATC
filgrastim; parenteral
19.2
12.2
18
10
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
28.2
12.2
16
6
I15.8
ICD-10 Finland
Other secondary hypertension
28.2
12.2
16
6
C08CA05
ATC
nifedipine; systemic
28.2
12.2
16
6
783
NOMESCO Finland
NA
49.0
12.0
14
*
JAF10
NOMESCO Finland
Repair of umbilical hernia
15.6
12.0
19
13
1AB02
NOMESCO Finland
NA
13.4
11.8
20
16
TFJ02
NOMESCO Finland
Muscle biopsy of heart
24.2
11.7
16
7
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
68.0
11.7
13
*
K65.0
ICD-10 Finland
Acute peritonitis
68.0
11.7
13
*
H66.9
ICD-10 Finland
Otitis media, unspecified
2.6
11.6
117
621
IEP02
NOMESCO Finland
Child-centred family therapy
4.9
11.6
39
91
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
9.0
11.6
24
29
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
5.1
11.5
37
82
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
+∞
11.5
11
*
YNB20
NOMESCO Finland
Storage of stem cells for transplant
+∞
11.5
11
*
L04AA05
ATC
[U] tacrolimus; systemic
+∞
11.5
11
*
K07.30
ICD-10 Finland
Spacing, abnormal of tooth or teeth
2.8
11.5
92
427
WW409
NOMESCO Finland
Other aferesis
125.2
11.5
12
*
JJC00
NOMESCO Finland
Allogenic transplantation of liver
125.2
11.5
12
*
K07.24
ICD-10 Finland
Open bite
5.5
11.4
34
69
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
36.8
11.4
14
*
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
5.6
11.1
32
63
GD1AD
NOMESCO Finland
Thorax CT examination
11.3
11.0
20
19
RK110
NOMESCO Finland
NA
10.3
11.0
21
22
SAB02
NOMESCO Finland
Oral and dental health check by dental hygienist or dental assistant
0.4
10.9
54
1085
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
8.6
10.8
23
29
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
13.7
10.8
18
14
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.4
10.8
40
103
UKC02
NOMESCO Finland
Cystoscopy
7.1
10.8
26
40
U14
ICPC
Kidney symptom/complaint
22.6
10.8
15
7
SFA40
NOMESCO Finland
Replacement of krone of tooth
6.7
10.8
27
44
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.6
10.8
51
164
TK810
NOMESCO Finland
Hemofiltration
62.6
10.7
12
*
N19
ICD-10 Finland
Unspecified kidney failure
62.6
10.7
12
*
KAB00
NOMESCO Finland
Biopsy of kidney or pelvis of kidney
62.6
10.7
12
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.9
10.7
75
318
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
6.9
10.6
26
41
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
6.3
10.6
28
49
AA1AD
NOMESCO Finland
CT of head and brain
5.0
10.5
34
76
Z49.0
ICD-10 Finland
Preparatory care for dialysis
+∞
10.5
10
*
Z94.2
ICD-10 Finland
Lung transplant status
+∞
10.5
10
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.6
10.4
92
448
N04.0
ICD-10 Finland
Nephrotic syndrome, minor glomerular abnormality
24.5
10.3
14
6
SFA10
NOMESCO Finland
Fillning on one surface of tooth
2.4
10.2
163
1071
TJF80
NOMESCO Finland
Ostomy education
12.0
10.2
18
16
WX302
NOMESCO Finland
Thoracal epidural anesthesy
9.7
10.2
20
22
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
15.4
10.1
16
11
KA1AE
NOMESCO Finland
Kidney ultrasound examination
8.2
10.1
22
29
TJW99
NOMESCO Finland
Other minor procedure in gastrointestinal endoscopy
41.8
10.0
12
*
A02BC05
ATC
esomeprazole; systemic
3.6
10.0
47
150
RS121
NOMESCO Finland
NA
7.0
10.0
24
37
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
6.0
10.0
27
49
L01BB02
ATC
mercaptopurine; oral
9.3
10.0
20
23
R11
ICD-10 Finland
Nausea and vomiting
3.2
9.9
55
199
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
21.0
9.9
14
7
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.4
9.9
193
1396
GAE10
NOMESCO Finland
Closure of previous incision of chest wall
8.4
9.8
21
27
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.9
9.8
27
50
A04AA01
ATC
ondansetron; systemic, rectal
4.6
9.8
34
82
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.2
9.7
54
196
WX1PA
NOMESCO Finland
Total body mineral density measurement with Dual energy X-ray absorptiometry (DXA)
10.6
9.7
18
18
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
10.6
9.7
18
18
RT150
NOMESCO Finland
NA
5.3
9.6
29
60
A01AB09
ATC
miconazole; local oral
5.3
9.6
29
60
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.7
9.5
77
354
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.7
9.5
27
52
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.8
9.5
70
305
WX704
NOMESCO Finland
Intubation
4.7
9.5
32
75
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
18.4
9.5
14
8
J01EA01
ATC
trimethoprim; systemic
3.7
9.4
42
128
2AX05
NOMESCO Finland
NA
+∞
9.4
9
*
K03.21
ICD-10 Finland
Erosion of teeth due to: persistent vomiting
+∞
9.4
9
*
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
2.3
9.4
149
964
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.3
9.4
49
170
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.2
9.4
52
188
XF404
NOMESCO Finland
Ambulatory ECG
3.9
9.3
39
113
RS210
NOMESCO Finland
NA
14.4
9.3
15
11
XKD00
NOMESCO Finland
Uroflowmetry
4.5
9.3
33
82
H52.0
ICD-10 Finland
Hypermetropia
3.9
9.3
38
108
K00.68
ICD-10 Finland
Other disturbance in the tooth eruption
3.9
9.3
38
108
FN1BB
NOMESCO Finland
Contrast angiography of heart and/or coronary arteries after bypass surgery
7.5
9.2
21
30
TJD20
NOMESCO Finland
Change of gastrostomy tube
7.0
9.2
22
34
JAB00
NOMESCO Finland
Division and ligature of inguinal hernia sac
5.9
9.2
25
46
1XC02
NOMESCO Finland
NA
38.1
9.1
11
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.6
8.9
74
344
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
4.4
8.9
32
80
Z31.5
ICD-10 Finland
Genetic counselling
3.3
8.9
46
158
B01.9
ICD-10 Finland
Varicella without complication
5.2
8.8
27
57
A06AD11
ATC
lactulose; oral
4.9
8.8
28
62
C07AG02
ATC
carvedilol; oral
51.7
8.7
10
*
61
HP
Catheterization and pressure measurement of the left side of the heart
51.7
8.7
10
*
H26.3
ICD-10 Finland
Drug-induced cataract
51.7
8.7
10
*
R1260
NOMESCO Finland
Evaluation of communicative skills
6.4
8.7
22
37
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
10.6
8.7
16
16
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
17.0
8.6
13
8
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.4
8.6
91
478
WW400
NOMESCO Finland
Plasmaferesis
28.6
8.5
11
*
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
28.6
8.5
11
*
K00.50
ICD-10 Finland
Dentinal dysplasia
20.8
8.5
12
6
TQW99
NOMESCO Finland
Other minor procedure on skin
7.1
8.5
20
30
A08.0
ICD-10 Finland
Rotaviral enteritis
6.6
8.5
21
34
ZX197
NOMESCO Finland
NA
92.9
8.5
9
*
K02.1
ICD-10 Finland
Caries of dentine
2.2
8.4
168
1177
K07.25
ICD-10 Finland
Anomalies of dental arch relationship
2.7
8.4
61
262
QXB05
NOMESCO Finland
Skin wound assessment, unspecified location
9.9
8.4
16
17
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.8
8.4
35
101
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
5.0
8.4
26
56
ZX196
NOMESCO Finland
NA
+∞
8.4
8
*
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
+∞
8.4
8
*
K06.10
ICD-10 Finland
Gingival fibromatosis
+∞
8.4
8
*
H01AC01
ATC
somatropin; parenteral
3.9
8.4
34
96
A08.2
ICD-10 Finland
Adenoviral enteritis
15.1
8.3
13
9
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
15.1
8.3
13
9
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.1
8.3
134
857
J01DB01
ATC
cefalexin; oral
2.2
8.3
190
1415
RK230
NOMESCO Finland
NA
8.6
8.2
17
21
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
10.5
8.1
15
15
A08.1
ICD-10 Finland
Acute gastroenteropathy due to Norovirus
34.5
8.1
10
*
H52.2
ICD-10 Finland
Astigmatism
4.1
8.1
31
83
K05.11
ICD-10 Finland
Gingivitis (chronic) hyperplastic
22.8
8.1
11
5
SCF02
NOMESCO Finland
Preventive oral care by dental hygienist
3.0
8.0
48
180
Q23.4
ICD-10 Finland
Hypoplastic left heart syndrome
11.3
7.9
14
13
G04BE03
ATC
sildenafil; oral
9.9
7.9
15
16
R63.8
ICD-10 Finland
Other symptoms and signs concerning food and fluid intake
9.9
7.9
15
16
H65.3
ICD-10 Finland
Chronic mucoid otitis media
2.6
7.9
61
272
TDM10
NOMESCO Finland
Puncture of maxillary antrum
7.8
7.8
17
23
C64.80
ICD-10 Finland
Wilms tumour
46.4
7.8
9
*
IEP03
NOMESCO Finland
Focused parental counselling
3.7
7.7
33
98
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
19.0
7.7
11
6
31
HP
Congenital heart failure surgery
19.0
7.7
11
6
FQA00
NOMESCO Finland
Orthotopic transplantation of heart
19.0
7.7
11
6
RS311
NOMESCO Finland
NA
12.4
7.7
13
11
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
12.4
7.7
13
11
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
3.4
7.6
36
116
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
2.4
7.5
72
357
NE1AA
NOMESCO Finland
Pelvis X-ray examination
5.9
7.5
20
36
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
6.3
7.5
19
32
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
8.0
7.5
16
21
R62.0
ICD-10 Finland
Delayed milestone
2.9
7.5
46
177
RS222
NOMESCO Finland
NA
4.8
7.5
24
54
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
82.3
7.5
8
*
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
3.6
7.4
33
101
WZC30
NOMESCO Finland
Teaching
3.3
7.4
37
124
J01FF01
ATC
clindamycin; systemic
3.2
7.4
38
130
ZX112
NOMESCO Finland
Subcutaneous
6.6
7.4
18
29
Z940, N0480
ICD-10 Finland
NA
+∞
7.3
7
*
N0480, Z940
ICD-10 Finland
NA
+∞
7.3
7
*
C01AA05
ATC
digoxin; systemic
+∞
7.3
7
*
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
+∞
7.3
7
*
TKA05
NOMESCO Finland
Aspiration cytology of kidney
+∞
7.3
7
*
SPAT1262
SPAT
Handing over of treatment supplies
3.5
7.3
34
108
1XX02
NOMESCO Finland
NA
16.3
7.3
11
7
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
5.3
7.3
21
42
UJF32
NOMESCO Finland
Coloscopy
3.4
7.3
35
114
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
6.9
7.2
17
26
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.2
7.2
37
127
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
20.7
7.2
10
5
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
20.7
7.2
10
5
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
2.6
7.2
56
248
SAB03
NOMESCO Finland
Oral health check
0.5
7.2
71
1155
FDA00
NOMESCO Finland
Aortoplasty and aorto-pulmonary shunt for HLHS
12.5
7.1
12
10
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
9.2
7.1
14
16
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
3.5
7.1
32
99
J01MA12
ATC
levofloxacin; systemic
6.7
7.1
17
27
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
3.9
7.0
28
78
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
3.5
7.0
32
100
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
14.3
6.9
11
8
K03.22
ICD-10 Finland
Erosion of teeth due to: diet
11.4
6.9
12
11
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.1
6.8
25
65
324
NOMESCO Finland
NA
17.2
6.8
10
6
3A077
NOMESCO Finland
NA
17.2
6.8
10
6
8960/3-C64.9
ICD-O-3
Nephroblastoma, NOS, of kidney, NOS
41.1
6.8
8
*
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
41.1
6.8
8
*
A41.8
ICD-10 Finland
Other specified sepsis
23.2
6.7
9
*
ZXX03
NOMESCO Finland
Extent of procedure, 3 units
23.2
6.7
9
*
2AX04
NOMESCO Finland
NA
23.2
6.7
9
*
Q44.21
ICD-10 Finland
Atresia of extrahepatic bile ducts
23.2
6.7
9
*
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
5.3
6.6
19
38
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
7.2
6.6
15
22
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
10.4
6.6
12
12
WX892
NOMESCO Finland
Monitored bed care
2.8
6.5
41
160
K01.14
ICD-10 Finland
Retained premolar with obstruction in the upper jaw
71.5
6.5
7
*
Q44.29
ICD-10 Finland
Atresia of bile ducts
14.8
6.4
10
7
RK260
NOMESCO Finland
NA
8.5
6.4
13
16
ZX100
NOMESCO Finland
Oral
8.5
6.4
13
16
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
18.6
6.3
9
5
K07.20
ICD-10 Finland
Crossbite (anterior)(posterior)
3.1
6.3
35
125
JJC50
NOMESCO Finland
Resection of transplanted liver
+∞
6.3
6
*
T86.1
ICD-10 Finland
Kidney transplant failure and rejection
+∞
6.3
6
*
9811/3-C42.1
ICD-O-3
B lymphoblastic leukemia/lymphoma, NOS, of bone marrow
27.4
6.3
8
*
JJC10
NOMESCO Finland
Allogenic partial transplantation of liver
27.4
6.3
8
*
TBW99
NOMESCO Finland
Other minor procedure in endocrine surgery
3.4
6.2
29
93
P85
ICPC
Mental retardation
5.1
6.2
18
37
K00.00
ICD-10 Finland
Hypodontia
3.4
6.2
28
88
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
12.9
6.1
10
8
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
12.9
6.1
10
8
FDF05
NOMESCO Finland
Percutaneous transluminal occlusion of aorto-pulmonary collaterals
12.9
6.1
10
8
RK320
NOMESCO Finland
NA
8.9
6.1
12
14
JDB10
NOMESCO Finland
Percutaneous gastrostomy
5.8
6.1
16
29
NF1AA
NOMESCO Finland
Hip X-ray examination
5.8
6.1
16
29
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
6.3
6.1
15
25
TQW80
NOMESCO Finland
Local dermatologic skincare
10.4
6.1
11
11
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
10.4
6.1
11
11
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
4.5
6.1
20
47
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.3
6.0
29
95
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
5.0
6.0
18
38
D64.9
ICD-10 Finland
Anaemia, unspecified
5.0
6.0
18
38
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
125
59
36.39
177.53
19.3
11.8
u/ml
156.6
2713.2
—
22
9
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
127
63
35.00
176.95
17.5
11.6
iu/ml
225.6
594.0
0.69
24
14
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
78
18
58.84
134.95
10.5
8.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
145
177
15.33
121.93
13.1
6.2
umol/l
311.3
279.6
1.89
145
169
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
65
12
69.46
117.06
8.0
7.1
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
67
16
54.10
114.41
6.8
6.2
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
67
16
54.10
114.41
7.1
6.3
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
70
28
32.60
102.97
5.6
5.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
151
247
11.63
99.95
6.2
4.3
e9/l
59.7
61.5
0.21
124
151
(3016244) Insulin [Units/volume] in Serum or Plasma
107
117
13.88
94.99
4.0
3.2
mu/l
13.1
29.4
1.61
107
110
(3022948) Iron [Moles/volume] in Serum or Plasma
170
339
10.66
94.62
8.7
2.7
umol/l
12.9
14.4
2.23
170
330
(3037121) Protein [Mass/volume] in Urine
117
151
12.29
92.24
11.7
7.9
g/l
0.2
0.3
0.93
108
122
(4035726)
95
94
14.52
89.73
2.7
1.7
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
108
130
12.62
89.33
4.4
1.9
u/ml
81.5
84.3
—
5
7
(3020779) Urea [Moles/volume] in Serum or Plasma
179
402
9.97
88.68
41.6
9.5
mmol/l
7.5
4.8
13.54
179
396
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
108
133
12.32
87.77
4.3
1.8
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
54
23
28.60
76.97
3.2
2.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
74
62
15.66
76.78
2.5
1.7
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
132
268
8.18
69.29
21.1
7.4
umol/l
5.4
8.0
0.81
121
216
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
108
187
8.59
65.20
4.2
1.7
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
108
187
8.59
65.20
4.2
1.7
u/ml
209.7
176.1
0.39
70
72
(3000991) Gas panel - Venous blood
196
633
7.42
63.06
32.0
8.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
65
61
13.43
62.41
3.1
1.8
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
43
19
26.38
60.04
3.7
3.4
—
—
—
0
0
(3026782) Osmolality of Urine
176
537
6.76
59.39
9.9
3.0
mosm/kgh2o
600.1
616.4
0.39
169
450
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
73
87
10.87
59.37
3.6
2.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
153
417
6.63
58.16
16.0
3.7
ph
7.4
7.4
1.91
30
54
(3000850) Epithelial cells [#/volume] in Urine
174
543
6.48
56.71
12.5
2.8
e6/l
3.9
5.6
2.09
169
464
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
165
491
6.45
56.70
7.7
2.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
70
87
10.28
54.97
3.4
2.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
62
66
11.67
54.46
3.2
1.9
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
58
56
12.69
54.39
3.1
1.8
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
194
699
6.33
52.77
29.5
7.3
kpa
5.4
5.1
1.18
194
682
(3044640) Blood type and Crossmatch panel - Blood
172
561
6.05
52.41
9.0
3.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
195
714
6.25
51.80
31.9
7.4
mmol/l
1.2
1.3
0.07
183
564
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
134
354
6.16
51.76
2.0
1.8
mmol/l
1.2
1.3
0.34
134
331
(3021447) Carbon dioxide [Partial pressure] in Venous blood
195
717
6.21
51.45
31.9
7.4
kpa
5.8
5.9
1.28
195
697
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
97
193
7.04
50.29
3.9
2.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
97
195
6.96
49.73
3.7
1.8
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
82
140
7.76
49.09
2.2
1.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
153
475
5.68
48.65
9.6
3.6
e6/l
0.5
0.6
0.09
132
282
(40758558) Short blood count panel - Blood
226
987
6.77
47.57
30.1
8.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
52
52
11.96
47.43
20.9
14.7
u/ml
0.3
0.3
0.94
36
33
(3033658) Prothrombin time (PT) actual/Normal
180
651
5.63
47.41
25.3
7.1
%
84.7
83.7
0.24
180
646
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
62
81
9.46
46.50
8.2
4.4
%
90.0
94.1
0.47
62
81
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
56
67
10.11
44.88
5.0
3.0
ml/min/173m2
45.3
106.2
8.83
16
17
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
53
59
10.76
44.79
2.3
1.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
193
766
5.51
44.64
16.0
3.9
e6/l
0.1
0.2
0.77
178
586
(44790047)
58
74
9.54
44.23
3.2
2.0
—
—
—
0
0
(44790049)
58
74
9.54
44.23
3.2
2.0
—
—
—
0
0
(44790048)
58
74
9.54
44.23
3.2
2.0
—
—
—
0
0
(44806118)
58
74
9.54
44.23
3.2
2.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
193
773
5.44
43.94
15.7
3.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
150
495
5.19
43.36
9.6
3.7
e6/l
1.5
1.5
0.05
129
305
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
101
240
5.91
42.90
4.0
2.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
52
60
10.33
42.74
4.4
3.8
umol/l
21.0
26.3
1.92
52
60
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
184
721
5.22
42.72
8.8
3.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
120
333
5.43
42.68
4.2
1.6
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
45
43
12.20
42.14
1.8
1.4
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
51
59
10.27
41.81
2.5
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
157
550
5.03
41.81
8.0
3.0
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
59
84
8.56
41.05
5.6
3.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
116
327
5.24
40.18
12.4
4.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
114
317
5.27
40.14
11.2
4.6
mg/l
3.4
2.2
0.42
101
214
(3018095) Leukocytes [#/volume] in Urine
207
934
5.21
39.02
21.2
4.7
e6/l
13.6
41.2
2.35
181
647
(42870588) Differential panel, method unspecified - Blood
245
1267
6.91
38.96
32.6
8.9
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
195
843
4.98
38.78
19.2
4.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
42
41
11.80
38.69
1.5
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
192
823
4.92
38.54
18.0
3.9
e6/l
11.1
18.8
1.29
180
638
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
42
42
11.52
38.05
3.1
2.8
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
59
92
7.79
37.82
5.3
3.3
e6/l
189.3
382.9
3.12
43
68
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
58
89
7.89
37.71
5.7
3.3
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
26
10
28.45
37.68
4.5
4.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
39
36
12.36
37.22
2.5
1.5
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
58
91
7.71
36.94
5.7
3.2
%
66.9
68.7
0.19
58
91
(3023323) Follitropin [Units/volume] in Serum or Plasma
88
209
5.60
36.90
3.2
2.6
iu/l
7.0
5.5
0.60
59
127
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
57
88
7.81
36.82
2.8
2.0
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
58
94
7.46
35.83
5.7
3.2
e9/l
1.0
1.5
2.50
45
70
(3032080) INR in Blood by Coagulation assay
127
419
4.60
35.48
10.0
3.9
inr
1.1
1.2
0.29
20
86
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
235
1236
5.68
34.76
56.7
9.5
mmol/l
1.2
1.2
0.22
229
1161
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
34
28
13.62
34.75
18.8
9.1
—
—
—
0
0
(3015736) pH of Urine
166
684
4.32
33.95
10.9
2.9
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
91
239
5.08
33.68
3.3
2.6
u/l
4.1
4.1
0.03
61
141
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
166
690
4.27
33.40
30.4
6.5
mmol/l
1.1
1.2
0.14
137
480
(3009343) pH of Capillary blood
166
691
4.26
33.31
30.6
6.6
ph
7.4
7.4
0.30
22
17
(3052851) Hemolysis interference index of Serum or Plasma
55
91
7.22
33.24
5.7
3.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
153
605
4.22
32.92
30.7
6.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
30
24
13.82
31.10
2.2
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
61
120
6.17
31.02
8.9
5.7
%
0.4
0.6
0.43
33
37
(1616796) Gas panel - Central venous blood
40
50
9.12
30.63
15.3
5.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
70
160
5.44
30.23
3.3
1.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
228
1246
4.83
30.05
25.6
6.7
mmol/l
5.6
6.1
7.50
223
1181
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
51
87
6.90
29.82
5.6
3.2
%
24.5
26.1
0.36
51
87
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
214
1121
4.44
29.82
8.1
2.6
mmol/l
2.4
2.6
4.77
214
1052
(3006315) Basophils [#/volume] in Blood
258
1556
6.80
29.82
38.6
8.8
e9/l
0.0
0.0
3.90
242
1261
(3001604) Monocytes [#/volume] in Blood
258
1560
6.77
29.61
38.7
8.8
e9/l
0.6
0.6
1.32
242
1264
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
215
1135
4.42
29.51
8.5
2.7
mmol/l
4.1
4.3
3.11
215
1089
(3002179) Metamyelocytes/100 leukocytes in Blood
57
110
6.20
29.50
8.1
4.9
%
0.3
0.6
0.81
27
26
(3034770) Mitochondria Ab [Titer] in Serum
40
53
8.59
29.20
2.9
2.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
259
1587
6.75
28.80
43.5
9.5
e9/l
0.2
0.2
1.58
246
1319
(3019198) Lymphocytes [#/volume] in Blood
259
1596
6.66
28.35
38.6
8.8
e9/l
2.1
2.3
3.57
246
1337
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
51
92
6.51
28.20
5.6
3.1
e6/l
384.0
532.3
1.26
38
73
(3042936) Bacteria identified in Isolate by Culture
81
221
4.69
28.18
3.5
1.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
56
111
6.01
28.13
8.9
5.9
%
0.0
0.0
0.00
28
31
(3026008) Bacteria identified in Urine by Culture
114
402
4.02
28.07
6.4
2.4
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
51
93
6.44
27.88
5.6
3.1
e9/l
0.1
0.2
2.73
38
74
(3021589) Normoblasts [#/volume] in Blood
250
1521
5.57
27.15
41.1
9.8
e9/l
0.0
0.0
0.16
230
1134
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
36
46
8.79
27.01
1.9
2.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
36
47
8.60
26.53
6.2
4.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
34
42
9.03
26.17
6.3
4.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
40
61
7.44
25.82
1.9
1.8
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
38
55
7.80
25.68
17.6
4.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
35
46
8.51
25.64
3.1
2.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
251
1569
5.36
25.33
37.8
8.7
%
50.0
48.1
1.87
251
1527
(3013650) Neutrophils [#/volume] in Blood by Automated count
258
1648
5.99
25.30
46.6
10.0
e9/l
3.2
3.3
0.61
243
1338
(3002030) Lymphocytes/100 leukocytes in Blood
254
1607
5.57
25.10
38.9
8.8
%
34.1
36.2
2.35
254
1561
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
25
21
12.93
25.05
3.0
1.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
92
303
3.98
24.57
3.7
1.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
34
46
8.24
24.29
6.9
3.8
e9/l
3.4
2.6
1.53
34
46
(3009261) Glucose [Presence] in Urine by Test strip
175
880
3.48
24.06
13.1
3.1
estimate
0.0
0.0
0.00
36
134
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
22
16
14.79
23.90
3.2
1.5
—
—
—
0
0
(3024932) HLA-DR beta [Type]
27
28
10.53
23.58
1.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
27
28
10.53
23.58
1.0
1.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
34
49
7.72
23.00
8.9
4.1
%
49.6
47.7
0.34
34
49
(3021440) Promyelocytes/100 leukocytes in Blood
52
116
5.24
22.76
9.5
5.7
%
0.0
0.0
0.02
32
34
(3021601) Nitrite [Presence] in Urine by Test strip
171
873
3.33
22.44
18.8
4.7
estimate
0.0
0.0
0.00
36
137
(3035350) Ketones [Presence] in Urine by Test strip
171
873
3.33
22.44
13.3
3.1
estimate
0.0
0.0
0.00
33
126
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
40
71
6.37
22.31
5.0
2.5
—
491.8
—
0
5
(3008757) Leukocyte morphology finding [Identifier] in Blood
35
54
7.23
22.28
6.3
4.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
222
1338
3.78
21.95
18.8
3.9
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
102
386
3.53
21.83
2.1
1.7
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
28
35
8.75
21.25
17.8
11.2
kpa
4.8
4.9
0.33
28
35
(3027315) Oxygen [Partial pressure] in Blood
28
35
8.75
21.25
17.8
10.1
kpa
11.1
8.6
5.15
28
35
(3012501) Base excess in Blood by calculation
28
35
8.75
21.25
17.8
11.2
mmol/l
0.8
1.5
0.93
14
20
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
137
641
3.15
20.38
4.3
3.8
mg/l
2.9
2.5
1.31
127
570
(3031040) Bacteria [#/volume] in Urine by Automated count
209
1257
3.35
19.78
17.4
3.3
e6/l
7.0
102.3
—
10
10
(3017143) Hepatitis C virus Ab [Presence] in Serum
82
287
3.59
19.58
2.2
1.5
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
28
40
7.64
19.00
2.9
2.4
umol/l
15.3
14.0
0.20
28
40
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
36
69
5.81
18.48
4.8
2.9
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
19
17
11.89
18.17
2.8
2.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
36
71
5.65
17.92
24.6
8.3
mmol/l
1.2
1.2
0.34
36
60
(3045142) Bone marrow Pathology biopsy report
24
32
8.08
17.22
2.2
1.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
20
21
10.15
17.19
2.1
2.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
42
99
4.79
17.07
2.1
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
42
99
4.79
17.07
2.1
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
22
27
8.73
16.86
2.1
1.8
—
—
—
0
0
(21494434) Karyotype in Bone marrow
21
26
8.63
15.96
1.5
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
33
67
5.43
15.88
10.9
4.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
92
394
2.95
15.28
2.1
1.6
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
14
10
14.66
15.14
1.3
1.2
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
17
17
10.56
15.05
9.6
4.8
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
17
18
9.97
14.46
2.3
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
16
16
10.52
14.14
2.4
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
56
188
3.45
13.93
3.1
2.2
nmol/l
9.6
8.7
0.29
42
134
(3037522) Nuclear Ab [Titer] in Serum
75
302
3.00
13.77
2.4
1.5
titre
265.0
707.7
1.29
16
39
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
35
86
4.49
13.45
2.8
1.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
88
391
2.79
13.45
21.6
4.8
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
18
23
8.28
13.30
2.5
3.1
umol/l
1.2
1.1
0.05
18
23
(3016038) Potassium [Moles/volume] in Urine
26
50
5.61
13.22
2.3
2.6
mmol/l
26.5
38.6
1.40
26
50
(3006184) Hemoglobin [Mass/volume] in Capillary blood
30
68
4.80
12.70
5.3
2.6
g/l
130.5
137.5
1.29
25
57
(3014148) Varicella zoster virus Ab [Titer] in Serum
33
81
4.47
12.68
1.2
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
36
95
4.18
12.61
1.3
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
30
69
4.73
12.48
27.6
15.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
18
25
7.61
12.41
1.0
1.4
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
18
25
7.61
12.41
1.0
1.4
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
18
25
7.61
12.41
1.0
1.4
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
18
25
7.61
12.41
1.0
1.4
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
18
25
7.61
12.41
1.0
1.4
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
18
25
7.61
12.41
1.0
1.4
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
18
26
7.31
11.99
1.1
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
39
117
3.69
11.42
24.7
13.4
mmol/l
-0.3
-0.3
0.01
31
97
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
151
919
2.34
11.40
28.4
5.7
ml/min/173m2
100.2
113.3
3.19
90
500
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
35
99
3.88
11.14
3.2
2.0
nmol/l
0.1
0.1
0.02
29
75
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
12
11
11.34
11.13
2.9
1.6
pg
32.4
33.7
0.38
12
11
(3002256) Pathology report gross observation
42
135
3.47
11.09
1.3
1.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
28
67
4.52
11.08
27.9
17.3
%
70.5
72.2
0.22
28
67
(3025941) Bacteria identified in Stool by Culture
31
81
4.16
10.98
1.6
1.2
—
—
—
0
0
(3020891) Body temperature
22
43
5.45
10.97
16.4
9.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
63
260
2.82
10.87
7.6
3.3
ng/l
616.0
1640.4
1.12
43
158
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
13
14
9.67
10.84
1.6
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
16
23
7.30
10.68
1.0
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
179
1193
2.30
10.62
4.1
2.1
mmol/l
5.2
5.4
1.65
172
1077
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
33
94
3.83
10.39
27.6
15.7
mmol/l
23.7
23.8
0.12
33
94
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
19
34
5.91
10.36
2.1
1.4
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
14
18
8.12
10.23
4.6
4.9
ug/l
247.4
234.2
0.07
14
18
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
30
82
3.96
9.99
1.3
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
95
496
2.36
9.98
2.3
2.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
16
25
6.71
9.91
1.4
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
48
179
3.01
9.91
3.7
2.5
u/l
42.9
29.6
0.49
43
153
(3039162) Centromere protein B Ab [Units/volume] in Serum
18
32
5.93
9.87
1.1
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
52
207
2.84
9.53
5.4
3.7
mg/l
271.0
139.9
0.68
46
165
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
14
8
18.30
9.49
3.4
7.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
44
160
3.06
9.47
2.0
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
13
6
22.58
9.43
3.5
1.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
12
14
8.90
9.41
1.9
1.0
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
18
34
5.58
9.28
1.6
1.6
nmol/l
13.8
17.2
—
5
12
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
19
38
5.28
9.23
6.1
3.9
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
19
38
5.28
9.23
6.1
3.9
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
18
35
5.42
9.00
1.1
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
23
57
4.30
8.70
1.7
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
271
2275
3.78
8.57
32.9
6.8
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
18
37
5.12
8.48
1.1
1.3
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
12
16
7.78
8.47
1.5
1.5
umol/l
15.7
16.7
0.32
12
16
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
24
63
4.06
8.43
3.2
2.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
22
54
4.33
8.42
1.2
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
40
148
2.97
8.33
1.6
1.5
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
15
27
5.80
8.10
9.4
3.4
ug/l
30.1
23.7
0.44
15
27
(3022145) Colonoscopy Study observation
30
95
3.41
8.07
1.6
1.5
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
12
17
7.32
8.05
1.8
1.2
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
19
44
4.55
7.80
1.1
1.3
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
12
18
6.91
7.66
2.0
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
12
18
6.91
7.66
2.0
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
12
18
6.91
7.66
2.0
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
10
12
8.59
7.62
1.6
1.7
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
10
12
8.59
7.62
1.6
1.3
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
10
12
8.59
7.62
1.3
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
10
12
8.59
7.62
1.6
1.3
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
14
25
5.83
7.62
1.8
1.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
18
41
4.61
7.54
1.1
1.3
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
10
5
20.63
7.18
1.6
1.0
pmol/l
5.9
—
—
5
0
(3023419) Bacteria identified in Sputum by Culture
10
5
20.63
7.18
15.7
10.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
10
13
7.93
7.16
1.8
3.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
72
380
2.19
7.10
2.1
1.4
pmol/l
104.0
96.6
0.86
38
178
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
12
20
6.22
6.96
1.3
1.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13
24
5.62
6.83
2.7
1.8
—
—
—
0
0
(3011648) Oxygen content in Venous blood
19
49
4.08
6.82
33.3
20.2
%
10.4
12.0
1.89
19
49
(3009871) Measles virus Ab [Titer] in Serum
11
9
12.64
6.63
1.8
2.7
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
11
9
12.64
6.63
2.2
2.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
280
2478
4.44
6.52
73.7
13.5
%
36.5
39.2
13.11
272
2268
(40761536) Microorganisms panel - Urine sediment
33
126
2.83
6.48
15.6
3.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
10
15
6.87
6.35
3.9
2.5
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
15
34
4.60
6.31
1.9
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
15
35
4.46
6.10
1.1
1.1
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
13
27
4.99
6.03
1.5
1.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
30
115
2.79
5.85
2.1
1.3
g/l
0.2
0.2
0.18
30
110
(3028433) Virus identified in Specimen by Culture
11
20
5.68
5.85
1.8
1.3
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
25
87
3.05
5.78
36.7
17.4
%
0.8
0.7
0.27
25
87
(3014007) Fractional oxyhemoglobin in Arterial blood
25
88
3.01
5.67
36.7
17.2
%
94.4
95.6
0.37
25
88
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
30
117
2.74
5.67
2.1
1.3
g/l
1.1
1.2
1.01
30
111
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
23
77
3.16
5.67
38.8
16.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
21
5.40
5.57
2.0
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
12
25
4.96
5.54
4.8
3.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
25
90
2.94
5.46
11.4
4.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
5
16.38
5.44
13.9
2.8
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
18
5.72
5.36
2.4
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
70
404
1.96
5.31
18.6
3.1
estimate
0.0
0.0
0.00
34
133
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
14
35
4.15
5.23
1.1
1.3
u/ml
2.0
3.1
—
9
21
(3007164) IgA [Mass/volume] in Serum or Plasma
156
1159
1.75
5.15
2.8
1.7
g/l
1.6
1.5
0.26
114
512
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
8
6
13.66
5.11
2.6
1.2
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
24
88
2.88
5.08
37.5
17.2
%
0.9
1.1
0.79
24
88
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
25
94
2.82
5.06
11.6
4.2
e6/l
525.4
584.6
0.04
20
70
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
25
94
2.82
5.06
11.6
4.2
e6/l
6.0
6.4
0.02
20
69
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
44
217
2.21
5.05
4.1
2.3
ng/l
106.2
16.5
1.03
29
78
(3016018) Differential panel - Cerebral spinal fluid
19
62
3.21
4.89
8.2
3.6
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
25
96
2.75
4.87
1.7
1.8
—
4.5
—
0
5
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
266
2356
2.50
4.84
57.7
9.6
mg/l
20.2
24.5
1.82
234
1479
(3003694) ABO and Rh group [Type] in Blood
100
671
1.75
4.63
1.8
1.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
5
14.29
4.60
3.0
2.6
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
7
5
14.29
4.60
3.1
2.4
u/field
0.3
26.4
—
7
5
(3035285) Chloride [Moles/volume] in Venous blood
7
5
14.29
4.60
3.0
2.6
mmol/l
106.7
106.4
—
7
5
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
21
4.90
4.56
1.2
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
21
4.90
4.56
1.2
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
21
4.90
4.56
1.2
1.7
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
24
95
2.66
4.42
6.3
2.9
umol/l
39.8
35.2
0.53
24
87
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
85
552
1.76
4.37
16.5
2.8
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
22
84
2.75
4.34
13.0
4.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
21
79
2.79
4.26
6.0
2.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9
13
7.10
4.19
1.9
2.8
u/ml
1813.4
1706.8
—
9
13
(3010503) CD19 cells [#/volume] in Blood
7
7
10.21
4.03
6.1
2.7
e9/l
0.1
0.1
—
7
7
(3041354) Potassium [Moles/volume] in Venous blood
7
7
10.21
4.03
3.0
2.1
mmol/l
4.6
3.7
—
7
7
(3041096) Erythrocytes [Presence] in Urine by Automated
63
385
1.81
3.94
16.0
2.7
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
23
95
2.54
3.91
12.4
4.2
mg/l
244.2
329.5
1.21
23
95
(3012898) Urea [Moles/volume] in Urine
6
5
12.21
3.78
1.5
1.2
mmol/l
156.7
208.6
—
6
5
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
24
104
2.43
3.71
1.6
1.4
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
7
9
7.93
3.58
2.1
1.4
—
—
—
0
0
(4306422)
10
26
3.95
3.55
1.1
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
6
10.17
3.51
1.3
2.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
6
10.17
3.51
1.3
2.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
6
10.17
3.51
1.3
2.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
32
161
2.11
3.50
2.0
1.4
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
7
10
7.14
3.38
1.7
2.3
—
—
—
0
0
(4062490)
16
60
2.76
3.28
1.4
1.3
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
7
8.72
3.28
1.3
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
8
15
5.45
3.21
1.4
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
7
11
6.49
3.20
1.1
1.4
u/l
28.3
23.8
—
7
11
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
18
73
2.56
3.19
1.6
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
9
20
4.61
3.14
2.0
1.8
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
20
4.61
3.14
1.3
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
44
258
1.83
3.13
3.2
1.8
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
14
50
2.89
3.13
1.1
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
14
50
2.89
3.13
1.1
1.2
%
95.7
75.9
0.87
14
50
(3019150) Specific gravity of Urine by Refractometry
65
427
1.67
3.13
13.0
2.5
kg/l
1.0
1.0
—
9
87
(40768443) Skin Pathology biopsy report
12
39
3.17
3.12
1.2
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
12
5.95
3.04
1.0
1.3
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
9
21
4.39
3.02
5.7
4.8
mmol/l
1.8
1.5
—
9
21
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
21
4.39
3.02
1.3
1.0
—
—
—
0
0
(4268621)
9
21
4.39
3.02
2.2
2.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
17
69
2.55
3.02
1.2
1.4
ug/g
372.0
361.8
—
10
38
(3019225) pH of Specimen
15
57
2.72
3.01
18.7
7.5
—
—
—
0
0
(40760512) CD34 cells/100 cells in Bone marrow
5
5
10.14
2.99
1.2
2.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
18
77
2.43
2.88
1.5
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
18
77
2.43
2.88
7.4
3.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
9
6.78
2.88
1.3
2.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
9
6.78
2.88
1.3
2.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
9
6.78
2.88
1.3
2.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
9
6.78
2.88
1.3
2.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
12
42
2.94
2.78
1.2
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
6
8.45
2.76
1.6
2.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
7
14
5.09
2.74
1.3
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
18
79
2.36
2.73
1.5
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
218
1917
1.55
2.65
4.5
3.6
mu/l
2.2
2.0
1.10
213
1803
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
7
15
4.75
2.61
1.6
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
18
81
2.30
2.60
1.5
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
20
4.08
2.58
3.1
1.9
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
15
62
2.50
2.58
4.9
1.8
—
—
—
0
0
(3000012) Reticulocyte production index
5
7
7.24
2.56
1.0
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
7
7.24
2.56
1.2
1.0
nmol/l
154.8
154.0
—
5
7
(3013512) EKG study
33
190
1.83
2.50
4.6
3.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
7
16
4.45
2.49
1.1
1.1
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
18
83
2.25
2.46
4.6
6.4
ug/l
2.8
2.0
0.55
18
83
(3048689) Calprotectin [Mass/mass] in Stool
78
566
1.52
2.44
4.5
3.5
ug/g
196.3
77.1
0.73
73
456
(3044889) 12 lead EKG panel
103
793
1.46
2.40
3.7
2.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
9
5.63
2.22
1.2
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
14
61
2.36
2.18
1.4
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
15
69
2.24
2.08
1.9
1.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
5
10
5.07
2.08
1.4
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
32
194
1.73
2.07
1.7
1.8
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
5
11
4.60
1.95
1.2
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
11
4.60
1.95
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
18
93
2.00
1.89
1.8
1.2
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
7
22
3.23
1.89
1.6
1.7
—
—
—
0
0
(4034850)
7
22
3.23
1.89
7.7
5.5
—
—
—
0
0
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
6
17
3.58
1.84
1.2
1.2
%
71.7
74.2
—
6
17
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
6
17
3.58
1.84
1.2
1.2
mu/l
384.5
471.2
—
6
17
(3002523) Influenza virus A Ag [Presence] in Specimen
18
94
1.98
1.84
1.7
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
11
47
2.39
1.80
1.7
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
7
24
2.96
1.73
1.1
1.6
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
13
3.89
1.72
2.4
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
14
69
2.08
1.67
2.4
1.5
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
14
3.61
1.62
1.2
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
14
3.61
1.62
1.2
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
24
146
1.70
1.56
2.5
1.8
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
27
2.63
1.52
1.0
1.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
21
2.89
1.51
15.8
2.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
94
765
1.34
1.49
2.2
1.9
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
16
3.16
1.44
1.2
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
16
3.16
1.44
1.2
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
16
3.16
1.44
1.0
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
22
2.76
1.44
1.7
1.5
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
7
29
2.45
1.40
1.0
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
17
2.97
1.36
1.2
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
34
2.39
1.30
1.1
1.0
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
5
115
0.42
1.28
1.2
1.1
—
15.4
—
0
18
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
8
36
2.26
1.25
1.3
2.2
%
124.9
112.7
—
8
36
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
37
2.19
1.22
1.1
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
20
2.53
1.15
12.6
3.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
7
30
2.37
1.13
1.1
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
30
2.37
1.13
1.7
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
40
298
1.40
1.10
1.7
1.8
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
8
41
1.98
1.09
3.1
2.4
nmol/l
3.6
2.5
—
8
36
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
32
2.22
1.09
1.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
140
1241
1.25
1.08
2.3
2.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
34
2.08
1.03
1.4
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
20
295
0.65
1.03
1.0
1.2
u/ml
0.4
5.3
—
6
101
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
5
23
2.19
0.98
1.0
1.3
umol/l
10.2
8.0
—
5
23
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
36
1.97
0.97
1.6
1.2
—
—
—
0
0
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
0
31
0.00
0.97
0.0
1.1
—
4.2
—
0
26
(3016273) Islet cell 512 Ab [Units/volume] in Serum
6
30
2.02
0.87
1.5
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
25
180
1.43
0.85
1.7
1.2
—
—
—
0
0
(3049233) Organic acids panel - Urine
0
25
0.00
0.79
0.0
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
40
1.77
0.71
1.4
2.8
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
5
27
1.87
0.68
1.0
1.0
g/l
171.0
161.4
—
5
27
(3035933) Granulocytes/100 leukocytes in Blood
5
93
0.53
0.68
1.0
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
22
164
1.37
0.64
3.8
2.7
u/l
26527.2
4826.4
—
5
48
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
141
0.63
0.62
1.1
1.1
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
20
148
1.38
0.61
1.3
1.1
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
86
0.57
0.57
1.2
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
5
90
0.55
0.56
1.2
1.1
—
10.9
—
0
24
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
26
204
1.30
0.56
1.3
1.3
—
—
—
0
0
(3000492) Spirometry study
21
160
1.34
0.55
1.9
1.5
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
9
62
1.47
0.53
1.0
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
39
1.55
0.53
3.5
1.6
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
14
100
1.42
0.53
1.1
1.3
u/ml
0.5
9.8
—
9
86
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
39
463
0.82
0.52
2.0
2.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
27
218
1.26
0.48
1.2
1.2
iu/ml
11.2
15.0
—
5
40
(3002621) Streptococcal DNAse B [Units/volume] in Serum
7
46
1.53
0.48
1.1
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
26
318
0.80
0.46
1.5
1.3
u/ml
1.8
4.2
1.07
17
225
(3008401) Mugwort IgE Ab [Units/volume] in Serum
24
295
0.80
0.45
1.2
1.2
u/ml
0.1
1.2
2.80
17
231
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
19
240
0.78
0.44
1.5
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
9
130
0.68
0.44
1.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
31
1.62
0.43
1.0
1.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
91
0.65
0.43
1.0
1.2
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
16
0.00
0.41
0.0
1.1
—
105.6
—
0
16
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
0
16
0.00
0.41
0.0
2.8
—
1.3
—
0
11
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
1.2
—
0.5
—
0
17
(3003888) Timothy IgE Ab [Units/volume] in Serum
25
300
0.82
0.39
1.2
1.2
u/ml
0.5
7.0
9.48
18
243
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
37
1.36
0.37
1.0
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
6
41
1.47
0.36
2.3
2.5
ug/l
0.6
1.2
—
6
33
(3016879) Cocaine [Presence] in Urine
19
232
0.81
0.35
1.6
2.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
44
1.37
0.34
3.7
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
17
136
1.27
0.34
1.2
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
12
91
1.33
0.34
2.9
1.8
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
11
144
0.75
0.34
1.2
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
52
1.35
0.31
1.1
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
52
1.35
0.31
1.4
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
52
1.35
0.31
1.1
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
54
1.30
0.30
1.3
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
13
103
1.27
0.28
1.1
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
21
247
0.84
0.28
1.6
2.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
63
1.28
0.28
1.1
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
63
1.28
0.28
1.1
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
63
1.28
0.28
1.1
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
63
1.28
0.28
1.1
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
117
0.76
0.28
1.2
1.2
—
—
—
0
0
(4010399)
16
131
1.23
0.28
1.8
1.6
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
8
67
1.20
0.26
1.0
1.0
mmol/l
19.2
19.5
—
8
67
(3006598) pH of Arterial cord blood
8
67
1.20
0.26
1.0
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
74
0.67
0.26
1.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
21
245
0.85
0.26
1.6
2.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
21
245
0.85
0.26
1.6
2.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
39
432
0.89
0.25
1.9
2.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
21
242
0.86
0.23
1.6
2.0
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
43
392
1.11
0.22
1.1
1.2
—
60.8
—
0
6
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
40
1.25
0.22
1.8
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
11.4
—
670.3
—
0
11
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
4.2
—
0.4
—
0
10
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
15
126
1.20
0.21
1.5
2.2
e9/l
4.0
4.1
0.06
15
121
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
26
231
1.14
0.20
1.4
1.2
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
14
0.00
0.20
0.0
1.1
—
12.8
—
0
14
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
11
90
1.23
0.19
1.5
1.4
iu/ml
0.0
0.0
—
6
26
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
36
391
0.91
0.17
1.1
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
250
2468
1.09
0.17
4.4
4.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
8
71
1.13
0.16
1.3
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
27
292
0.92
0.12
2.6
2.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
23
248
0.92
0.10
2.0
1.9
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
19
205
0.92
0.08
1.5
2.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
56
579
0.96
0.07
1.2
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
8
90
0.89
0.07
1.3
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
124
1220
1.03
0.06
1.6
2.0
u/ml
5.6
4.7
0.07
15
184
(3047007) Chlamydophila sp Ab [Presence] in Serum
12
130
0.92
0.04
1.1
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
17
171
0.99
0.00
2.1
2.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
14
137
1.02
0.00
1.6
2.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013931) Oligosaccharides [Presence] in Urine
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4211845)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(4024509)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
9
95
0.95
0.00
1.3
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
9
98
0.92
0.00
1.7
1.9
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
9
96
0.94
0.00
1.1
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012787) Ethosuximide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.7
—
421.2
—
0
6
(44813793)
5
59
0.84
0.00
1.0
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
1150.6
—
0
9
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
11.5
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint K11_HYPOPLASIA_ENAMEL and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have K11_HYPOPLASIA_ENAMEL.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: K11_HYPOPLASIA_ENAMEL – Hypoplasia of dental enamel, including avohilmo
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data